Abstract
Background: Genome wide association studies shows SORT1 expression to affect lipid metabolism and thus identifies it as a risk gene for coronary artery disease (CAD). Higher circulating levels of Sortilin in patients with atherosclerosis is reported. However very little is known about its expression in patients with CAD. In hepatocytes, Sortilin interacts with PCSK9 in Trans Golgi network and helps its secretion from liver. In macrophages, Sortilin promotes LDL uptake, form cell formation and atherosclerosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
